Wednesday, March 22, 2023
Village Voice News
ADVERTISEMENT
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us
No Result
View All Result
Village Voice News
No Result
View All Result
Home Global

Rich countries hoarding Covid vaccines, says People’s Vaccine Alliance

Staff Reporter by Staff Reporter
December 9, 2020
in Global
IMAGE COPYRIGHTEPA

IMAGE COPYRIGHTEPA

0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Support Village Voice News With a Donation of Your Choice.

 

IMAGE COPYRIGHTEPA

BBC – Rich countries are hoarding doses of Covid vaccines and people living in poor countries are set to miss out, a coalition of campaigning bodies warns.

READ ALSO

China launches tourism promotion activities in Beijing

Highlights of Xi and Putin’s talks in Russia

The People’s Vaccine Alliance says nearly 70 lower-income countries will only be able to vaccinate one in 10 people.

This is despite Oxford-AstraZeneca pledging to provide 64% of its doses to people in developing nations.

Advertisement

Steps are being taken to ensure access to vaccines is fair around the globe.

This vaccine commitment, known as Covax, has managed to secure 700 million doses of vaccines to be distributed between the 92 lower-income countries that have signed up.

But even with this plan in place, the People’s Vaccine Alliance – a network of organisations including Amnesty International, Oxfam and Global Justice Now – says there is not enough to go round, and drug companies should share their technology to make sure more doses are produced.

Their analysis found that rich countries have bought enough doses to vaccinate their entire populations three times over if all the vaccines are approved for use.

Canada, for example, has ordered enough vaccines to protect each Canadian five times, it claims.

And even though rich nations represent just 14% of the world’s population, they have bought up 53% of all the most promising vaccines so far.

“No-one should be blocked from getting a life-saving vaccine because of the country they live in or the amount of money in their pocket,” said Anna Marriott, Oxfam’s health policy manager.

“But unless something changes dramatically, billions of people around the world will not receive a safe and effective vaccine for Covid-19 for years to come.”

The People’s Vaccine Alliance is calling on all pharmaceutical corporations working on Covid-19 vaccines to openly share their technology and intellectual property so that billions more doses can be manufactured and made available to everyone who needs them.

This can be done through the World Health Organization Covid-19 technology access pool, it says.

AstraZeneca, the company manufacturing the Covid vaccine developed by the University of Oxford, has committed to making it available on a not-for-profit basis to the developing world.

It is cheaper than the others and can be stored at fridge temperatures, making it easier to distribute across the globe.

But campaigners say one company on its own cannot supply enough vaccines for the whole world.

The Pfizer-BioNTech vaccine has already received approval in the UK and the most vulnerable are starting to be vaccinated this week. It is likely to receive approval from regulators in the US and Europe soon, meaning it could be some time before it is shared with poorer nations.

Two other vaccines, from Moderna and Oxford-AstraZeneca, are awaiting regulatory approval in a number of countries.

The Russian vaccine, Sputnik, has also announced positive trial results, and four other vaccines are going through late-stage clinical trials.



Support Village Voice News With a Donation of Your Choice



ShareTweetSendShareSend

Related Posts

Global

China launches tourism promotion activities in Beijing

by Admin
March 22, 2023

BEIJING, (Xinhua) -- China's Ministry of Culture and Tourism launched a program to promote tourism in the country in Beijing...

Read more
Chinese President Xi Jinping shakes hands with Russian President Vladimir Putin at the Kremlin in Moscow, Russia, March 21, 2023. Xi on Tuesday held talks with Putin in Moscow. Putin held a solemn welcome ceremony for Xi Jinping at the St. George's Hall. (Xinhua/Xie Huanchi)
Global

Highlights of Xi and Putin’s talks in Russia

by Admin
March 22, 2023

MOSCOW, March 22 (Xinhua) -- During his three-day visit to Russia starting on Monday, Chinese President Xi Jinping and Russian...

Read more
SONG CHEN/CHINA DAILY
Global

Creation of new agency ensures success of SARs

by Admin
March 21, 2023

On Thursday, Beijing announced the establishment of the Hong Kong and Macao work office of the Central Committee of the...

Read more
Next Post
IMAGE COPYRIGHTEPA : Private company Service Aérien Français runs air services across France

France helicopter crash: Five killed in Alps

EDITOR'S PICK

Early morning accident on  La Jalousie Public Road

March 17, 2021

GTT pumps $24M into Oil & Gas Chamber to train young Guyanese 

December 10, 2021
Osafo Grundall

Curl-up wanted for Lodge murder

February 24, 2021

Two more die from COVID-19

January 26, 2021

© 2022 Village Voice | Developed by Ink Creative Agency

No Result
View All Result
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us

© 2022 Village Voice | Developed by Ink Creative Agency